Treatment of Hypophysitis with Central Hypothyroidism Identified on Biochemical Testing
In patients with hypophysitis, biochemical evaluation of the pituitary-thyroid axis may reveal central hypothyroidism — a finding that requires targeted management distinct from primary thyroid disease.
Clinical Scenario
Central hypothyroidism is identified on biochemical testing of the pituitary-thyroid axis in the setting of hypophysitis. This reflects impaired thyroid-stimulating hormone secretion from the inflamed or damaged pituitary, resulting in inadequate thyroid hormone production.
Treatment Approach
Management centres on thyroid hormone replacement therapy, with biochemical follow-up targeting a specific free thyroxine level within a defined portion of the reference range.
Clinical Target
The goal of therapy is to achieve a free thyroxine level in the mid to upper half of the reference range, assessed through serial biochemical monitoring.
References
DOI: 10.1016/j.beem.2019.101371
Central hypothyroidism is treated with levothyroxine (average dose of 1.6 mcg/Kg/day) and the biochemical follow-up should be via measurement of free thyroxine levels, with a goal level of mid to upper half of the reference range.
View source ↗